• L1023 Anti-Cancer Compound Library Workflow

  2026-09-22

  Build pathway-aware phenotypic screens around 1,164 pre-dissolved compounds, then connect viability hits to kinase, apoptosis, mTOR, and STING-informed mechanisms. This workflow emphasizes practical plate handling, controls, orthogonal validation, and troubleshooting for reproducible cancer research.

• Cy3 Maleimide for Mechanistic DNA Repair Assays

  2026-09-22

  Cy3 maleimide enables selective thiol labeling for fluorescence microscopy imaging, but its greatest value emerges when probe chemistry is matched to assay logic. This article explains how to use non-sulfonated Cy3 maleimide to distinguish molecular localization, biomolecular assembly, and direct interaction in replication-stress studies.

• Bestatin Hydrochloride: Practical Assay Workflows

  2026-09-21

  Bestatin hydrochloride, also known as Ubenimex, supports mechanism-driven studies spanning aminopeptidase activity, neuronal peptide processing, endothelial tube formation, and cancer research. This guide translates reference findings into practical workflows, controls, dose selection, and troubleshooting strategies for angiogenesis inhibition and tumor biology assays.

• Cy3 TSA Fluorescence System Kit for NET-DNA Studies

  2026-09-21

  The Cy3 TSA Fluorescence System Kit provides a practical route to amplify weak protein and nucleic-acid signals in intestinal inflammation models, including NET-DNA, ILC3, and epithelial-repair workflows. This application-focused guide connects tyramide chemistry with controls, imaging decisions, and troubleshooting for IHC, ICC, and ISH experiments.

• Anti-ROR1 Antibody: From ROR1 Biology to Liver Models

  2026-09-20

  A translational framework for using Zilovertamab to validate ROR1 biology, design rigorous Wnt5a pathway assays, and explore—without overstating evidence—whether ROR1 modulation is relevant to deoxynivalenol-induced liver injury.

• TG003 Cdc2-like Kinase Inhibitor Workflows

  2026-09-19

  TG003 connects Clk-dependent serine/arginine-rich protein phosphorylation with measurable splice-site changes and cancer-resistance assays. This practical guide explains stock preparation, pathway-aware controls, platinum-response experiments, and troubleshooting for alternative splicing and ovarian cancer models.

• Bestatin hydrochloride: From Neuropeptides to Angiogenesis

  2026-09-19

  Bestatin hydrochloride (Ubenimex) connects aminopeptidase inhibition with practical workflows for neuronal peptide processing, endothelial tube formation, and cancer research. This guide translates a landmark electrophysiology study into assay design, dosing, controls, and troubleshooting strategies.

• Dihydrotestosterone Workflows for AR Research

  2026-09-18

  Dihydrotestosterone provides a controlled androgen receptor input for mapping AR-driven transcription, EGFR signaling pathway activation, and therapy-resistance phenotypes. This workflow connects DHT cell assays with osteoblast–prostate cancer models while separating established evidence from testable experimental hypotheses.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-09-17

  Learn how to use an ARCA-capped, polyadenylated IVT workflow for vaccine research, translation assays, antisense RNA, and RNA interference experiments. This practical guide connects upstream mRNA quality control with the spleen-targeted neoantigen vaccine findings reported in hepatocellular carcinoma research.

• Bestatin and Angiotensin III in Rat Brain

  2026-09-17

  The 1987 Brain Research study used iontophoretic electrophysiology and selective aminopeptidase inhibitors to test whether angiotensin II must be converted to angiotensin III before activating neurons. Bestatin enhanced responses to both peptides, whereas amastatin selectively suppressed angiotensin II responses, providing pharmacological evidence for an angiotensin II-to-angiotensin III activation pathway.

• 1-myristoylglycerophosphocholine in Fibrosis Assays

  2026-09-16

  Use 1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, as a defined lysophospholipid challenge for epithelial–fibroblast signaling, lipid metabolism, and smooth muscle experiments. This workflow emphasizes fresh preparation, species-resolved controls, and mechanistic validation rather than treating generic LysoPC activity as compound-specific evidence.

• Cy3 TSA Fluorescence System Kit for Cancer Imaging

  2026-09-16

  Use the Cy3 TSA Fluorescence System Kit to visualize scarce proteins, transcripts, and spatial relationships that conventional fluorescence may miss. This practical guide connects TSA workflow design with the p53-R280K/SREBP1/FASN breast cancer model and provides optimization advice for IHC, ICC, and ISH.

• GCLC Truncation and Delayed Age-Related Cataract

  2026-09-15

  Wei et al. identify age-related truncation of GCLC at Asp499 as a potential molecular explanation for declining lens glutathione and demonstrate that preventing this event delays cataract formation in mice. Their D499E knock-in model links preservation of GCLC integrity with improved redox protection, while also highlighting the need for human validation before therapeutic translation.

• GPER1 as a Chemoprevention Target in Prostate Cancer

  2026-09-15

  The reference study identifies GPER1 as a potentially protective receptor during the transition from high-grade prostatic intraepithelial neoplasia to prostate cancer. Using human samples, public datasets, TRAMP mice, and cell-based pharmacology and gene-silencing experiments, it shows that GPER1 activation suppresses tumor progression and epithelial-to-mesenchymal transition, while loss of GPER1 promotes invasive behavior.

• OTUD3–SLC7A11 Axis in Sunitinib-Resistant ccRCC

  2026-09-14

  The reference study identifies OTUD3 as a driver of sunitinib resistance in clear cell renal cell carcinoma by stabilizing the cystine transporter SLC7A11 and suppressing ferroptosis. Its findings connect deubiquitination, cystine utilization, redox control, and drug response, suggesting that OTUD3–SLC7A11 signaling may be a mechanistic target for restoring sunitinib sensitivity.

8058 records 1/538 page Next 12345 下5页 Last page